For following the competition: what moved in each program, several studies read as one move.
- Anti-PD-L1 Antibody-drug Conjugate HLX43
- serplulimab
- pimurutamab
- + 44 more
Mondays · ranked, phase 3 first · readouts ahead · See a sample brief
Add Fosun Pharma to watchlistEvery Monday by email · turn it off any timePro · free during the beta